跳轉至內容
Merck
全部照片(1)

重要文件

G005826

LC/MS (TOF) Analysis of Dermorphin on Ascentis® Express F5

application for HPLC

登入查看組織和合約定價


About This Item

技術

HPLC: suitable

測試參數

column: Ascentis Express F5, 10 cm x 2.1 mm I.D., 2.7 μm particles (53569-U)
mobile phase: 2 mM ammonium formate (90:10 acetonitrile:water) adjusted to pH 4.5 with formic acid
flow rate: 0.4 mL/min
column temp.: 35 °C
detector: ESI(+), TIC 100 – 1000 m/z; APCI (+), XIC m/z = 150.1, 203.7, 378.2
injection: 1 μL
sample: 10 μg/mL in 75:25 acetonitrile:water

適合性

application for HPLC

應用

forensics and toxicology

分析報告

Dermorphin is a heptapeptide derived from frogs. It is a painkiller and used illicitly in racehorses so they continue to run through the pain. A rapid analysis of dermorphin standard is shown here on an Ascentis Express F5 column. The HILIC mode separation provided the necessary retention and MS-compatibility, while the pentafluorophenyl (F5) phase chemistry elimated the chelating interactions that are problematic on bare silica.

法律資訊

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

分析物

描述

    Dermorphin trifluoroacetate salt, ≥98% (HPLC)

從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務